Literature DB >> 26477293

Short-term hyperprolactinemia decreases allergic inflammatory response of the lungs.

Julieta E Ochoa-Amaya1, Eduardo K Hamasato2, Carla N Tobaruela2, Nicolle Queiroz-Hazarbassanov2, Janete A Anselmo Franci3, João Palermo-Neto2, Flavia R Greiffo4, Auriléia Aparecida de Britto4, Rodolfo Paula Vieira4, Ana P Ligeiro de Oliveira4, Cristina de O Massoco2, Luciano F Felicio5.   

Abstract

AIMS: Prolactin is a major immunomodulator. The present study evaluated the effects of short-term hyperprolactinemia induced by domperidone before ovalbumin antigenic challenge on the lung's allergic inflammatory response. MAIN
METHODS: To induce hyperprolactinemia, domperidone was injected in rats at a dose of 5.1mg·kg(-1) per day, i.p., for 5days from 10th to 14th day after OVA immunization. Total and differential leukocyte counts from bronchoalveolar lavage (BAL), femoral marrow lavage (FML), and blood were analyzed. The percentages of mucus and collagen production were evaluated. Levels of corticosterone and prolactin in serum, interleukin-4 (IL-4), IL-6, IL-10, tumor necrosis factor α (TNF-α) in lung explants supernatants were measured and interferon gamma (IFN-γ) in bronchiolar lavage cells suspensions (BAL) was measured. KEY
FINDINGS: The rats that were subjected to short-term hyperprolactinemia exhibited a decrease in leukocyte counts in bronchoalveolar lavage, cellularity decrease in femoral marrow lavage fluid, a lower percentage of mucus, and an increase in lung IL-4, IL-6, IL-10, TNF-α and IFN-γ expression. SIGNIFICANCE: Hyperprolactinemia induced before antigenic challenge decreased allergic lung inflammation. These data suggest that prolactin may play a role in the pathophysiology of asthma. The present study demonstrates a prospective beneficial side effect of domperidone for asthmatic patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Domperidone; Lung; Prolactin

Mesh:

Substances:

Year:  2015        PMID: 26477293     DOI: 10.1016/j.lfs.2015.10.016

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets.

Authors:  Yaoyang Liu; Zhiguo Zhang; Qianmei Jin; Yang Liu; Zijian Kang; Yongbao Huo; Zhengwen He; Xu Feng; Jian Yin; Xin Wu; Huaizhou Wang; Huji Xu
Journal:  Endocrine       Date:  2019-03-18       Impact factor: 3.633

Review 2.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

3.  Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?

Authors:  Amarnath Sen
Journal:  Med Hypotheses       Date:  2020-08-24       Impact factor: 1.538

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.